Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 14
2004 14
2005 14
2006 18
2007 12
2008 10
2009 12
2010 11
2011 21
2012 19
2013 24
2014 29
2015 19
2016 11
2017 11
2018 17
2019 20
2020 24
2021 23
2022 17
2023 17
2024 18
2025 13
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Results by year

Filters applied: . Clear all
Page 1
A highly photostable and bright green fluorescent protein.
Hirano M, Ando R, Shimozono S, Sugiyama M, Takeda N, Kurokawa H, Deguchi R, Endo K, Haga K, Takai-Todaka R, Inaura S, Matsumura Y, Hama H, Okada Y, Fujiwara T, Morimoto T, Katayama K, Miyawaki A. Hirano M, et al. Among authors: okada y. Nat Biotechnol. 2022 Jul;40(7):1132-1142. doi: 10.1038/s41587-022-01278-2. Epub 2022 Apr 25. Nat Biotechnol. 2022. PMID: 35468954 Free PMC article.
StayGold variants for molecular fusion and membrane-targeting applications.
Ando R, Shimozono S, Ago H, Takagi M, Sugiyama M, Kurokawa H, Hirano M, Niino Y, Ueno G, Ishidate F, Fujiwara T, Okada Y, Yamamoto M, Miyawaki A. Ando R, et al. Among authors: okada y. Nat Methods. 2024 Apr;21(4):648-656. doi: 10.1038/s41592-023-02085-6. Epub 2023 Nov 30. Nat Methods. 2024. PMID: 38036853 Free PMC article.
Japan Stroke Society Guideline 2021 for the Treatment of Stroke.
Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, Iguchi Y, Shiokawa Y, Takagi Y, Ohtsuki T, Kinouchi H, Okada Y, Takahashi JC, Nakase H, Kakuda W; Committee for Stroke Guideline 2021, the Japan Stroke Society. Miyamoto S, et al. Among authors: okada y. Int J Stroke. 2022 Oct;17(9):1039-1049. doi: 10.1177/17474930221090347. Epub 2022 Apr 20. Int J Stroke. 2022. PMID: 35443847 Free PMC article.
The mitochondrial intermembrane space protein mitofissin drives mitochondrial fission required for mitophagy.
Fukuda T, Furukawa K, Maruyama T, Yamashita SI, Noshiro D, Song C, Ogasawara Y, Okuyama K, Alam JM, Hayatsu M, Saigusa T, Inoue K, Ikeda K, Takai A, Chen L, Lahiri V, Okada Y, Shibata S, Murata K, Klionsky DJ, Noda NN, Kanki T. Fukuda T, et al. Among authors: okada y. Mol Cell. 2023 Jun 15;83(12):2045-2058.e9. doi: 10.1016/j.molcel.2023.04.022. Epub 2023 May 15. Mol Cell. 2023. PMID: 37192628 Free PMC article.
Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.
Okazaki S, Tanaka K, Yazawa Y, Doijiri R, Koga M, Ihara M, Yamamoto S, Kamiyama K, Honda Y, Uchida K, Yoshimoto T, Asakura K, Omae K, Tanaka K, Maeda H, Yamamoto H, Hirano T, Toyoda K, Iguchi Y, Noguchi T, Okada Y, Kitagawa K, Sakai N, Yamagami H; ATIS-NVAF Trial Investigators. Okazaki S, et al. Among authors: okada y. JAMA Neurol. 2025 Dec 1;82(12):1227-1234. doi: 10.1001/jamaneurol.2025.3662. JAMA Neurol. 2025. PMID: 41051787 Clinical Trial.
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M, Nagai R. Taguchi I, et al. Among authors: okada y. Circulation. 2018 May 8;137(19):1997-2009. doi: 10.1161/CIRCULATIONAHA.117.032615. Circulation. 2018. PMID: 29735587 Free PMC article. Clinical Trial.
Epigenetic plasticity safeguards heterochromatin configuration in mammals.
Fukuda K, Shimi T, Shimura C, Ono T, Suzuki T, Onoue K, Okayama S, Miura H, Hiratani I, Ikeda K, Okada Y, Dohmae N, Yonemura S, Inoue A, Kimura H, Shinkai Y. Fukuda K, et al. Among authors: okada y. Nucleic Acids Res. 2023 Jul 7;51(12):6190-6207. doi: 10.1093/nar/gkad387. Nucleic Acids Res. 2023. PMID: 37178005 Free PMC article.
Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis.
Kitagawa K, Yamamoto Y, Arima H, Maeda T, Sunami N, Kanzawa T, Eguchi K, Kamiyama K, Minematsu K, Ueda S, Rakugi H, Ohya Y, Kohro T, Yonemoto K, Okada Y, Higaki J, Tanahashi N, Kimura G, Umemura S, Matsumoto M, Shimamoto K, Ito S, Saruta T, Shimada K; Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group. Kitagawa K, et al. Among authors: okada y. JAMA Neurol. 2019 Nov 1;76(11):1309-1318. doi: 10.1001/jamaneurol.2019.2167. JAMA Neurol. 2019. PMID: 31355878 Free PMC article.
Phase separation organizes the site of autophagosome formation.
Fujioka Y, Alam JM, Noshiro D, Mouri K, Ando T, Okada Y, May AI, Knorr RL, Suzuki K, Ohsumi Y, Noda NN. Fujioka Y, et al. Among authors: okada y. Nature. 2020 Feb;578(7794):301-305. doi: 10.1038/s41586-020-1977-6. Epub 2020 Feb 5. Nature. 2020. PMID: 32025038
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K; CSPS.com Trial Investigators. Toyoda K, et al. Among authors: okada y. Lancet Neurol. 2019 Jun;18(6):539-548. doi: 10.1016/S1474-4422(19)30148-6. Lancet Neurol. 2019. PMID: 31122494 Clinical Trial.
343 results